Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Loss from Continuing Operations Before Income Taxes |
Components of income before income taxes for the years ended December 31, 2024, 2023, and 2022 were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
United States |
|
$ |
22,838 |
|
|
$ |
68,166 |
|
|
$ |
68,416 |
|
Foreign |
|
|
(119 |
) |
|
|
2,776 |
|
|
|
773 |
|
Income before income taxes |
|
$ |
22,719 |
|
|
$ |
70,942 |
|
|
$ |
69,189 |
|
|
| Schedule of Components of Income Tax Expense |
During the years ended December 31, 2024, 2023, and 2022, significant components of income tax expense (benefit) were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
State and local income tax expense |
|
$ |
256 |
|
|
$ |
326 |
|
|
$ |
248 |
|
U.S. federal income tax expense |
|
|
3,048 |
|
|
|
1,084 |
|
|
|
15 |
|
Foreign federal income tax expense |
|
|
3,867 |
|
|
|
1,250 |
|
|
|
— |
|
Current income tax expense |
|
|
7,171 |
|
|
|
2,660 |
|
|
|
263 |
|
State and local income tax expense (benefit) |
|
|
2,696 |
|
|
|
(5,572 |
) |
|
|
— |
|
U.S. federal income tax expense (benefit) |
|
|
2,650 |
|
|
|
(38,915 |
) |
|
|
— |
|
Foreign federal income tax benefit |
|
|
(4,100 |
) |
|
|
(372 |
) |
|
|
(1,853 |
) |
Deferred income tax expense (benefit) |
|
|
1,246 |
|
|
|
(44,859 |
) |
|
|
(1,853 |
) |
Income tax expense (benefit) |
|
$ |
8,417 |
|
|
$ |
(42,199 |
) |
|
$ |
(1,590 |
) |
|
| Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of income taxes computed at the U.S. federal statutory income tax rate of 21% to the rate of our income tax expense (benefit) for the years ended December 31, 2024, 2023, and 2022 was as follows:
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
2024 |
|
2023 |
|
2022 |
U.S. federal statutory income tax rate |
|
21.0% |
|
21.0% |
|
21.0% |
State income taxes |
|
3.1% |
|
2.2% |
|
1.8% |
Foreign rate differential |
|
(1.9)% |
|
0.4% |
|
0.1% |
Redeemable noncontrolling interests |
|
(1.9)% |
|
(10.9)% |
|
(12.3)% |
Change in valuation allowance |
|
(21.6)% |
|
(131.9)% |
|
(23.1)% |
Deferred tax partnership adjustment |
|
6.8% |
|
30.8% |
|
10.1% |
Research and development credit |
|
(4.6)% |
|
(1.1)% |
|
(0.5)% |
Limitation on compensation deductions |
|
13.1% |
|
1.5% |
|
—% |
Equity-based compensation shortfall |
|
6.5% |
|
—% |
|
—% |
Tax rate change |
|
13.1% |
|
—% |
|
—% |
Other |
|
3.4% |
|
(0.1)% |
|
0.6% |
Impact of restructuring |
|
—% |
|
28.6% |
|
—% |
Income tax expense (benefit) |
|
37.0% |
|
(59.5)% |
|
(2.3)% |
|
| Schedule of Deferred Tax Assets and Liabilities |
As of December 31, 2024 and 2023, our deferred tax balances consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
|
2024 |
|
|
2023 |
|
Deferred tax assets – net |
|
|
|
|
|
|
Net operating loss |
|
$ |
12,487 |
|
|
$ |
11,972 |
|
Interest carryforwards |
|
|
20,126 |
|
|
|
16,689 |
|
Investment in partnership |
|
|
28,446 |
|
|
|
44,894 |
|
Tax Receivable Agreement |
|
|
38,232 |
|
|
|
40,994 |
|
Equity-based compensation |
|
|
3,797 |
|
|
|
2,665 |
|
Other |
|
|
3,037 |
|
|
|
1,914 |
|
Deferred tax assets |
|
|
106,125 |
|
|
|
119,128 |
|
Less: valuation allowance |
|
|
(26,182 |
) |
|
|
(32,318 |
) |
Total deferred tax assets – net |
|
$ |
79,943 |
|
|
$ |
86,810 |
|
Deferred tax liabilities |
|
|
|
|
|
|
Intangible assets |
|
$ |
6,779 |
|
|
$ |
9,841 |
|
Other |
|
|
61 |
|
|
|
1,848 |
|
Total deferred tax liabilities |
|
$ |
6,840 |
|
|
$ |
11,689 |
|
Net deferred tax asset / (liabilities) |
|
$ |
73,103 |
|
|
$ |
75,121 |
|
|
| Summary Of Valuation Allowance |
The following table summarizes the changes in the carrying amount of our deferred tax asset valuation allowance in 2024, 2023, and 2022 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
Valuation allowance at beginning of year |
|
$ |
32,318 |
|
|
$ |
118,734 |
|
|
$ |
145,668 |
|
Prior period adjustments(1) |
|
|
— |
|
|
|
(14,536 |
) |
|
|
(6,154 |
) |
Credited to costs and expenses |
|
|
(4,897 |
) |
|
|
(72,968 |
) |
|
|
(15,961 |
) |
Charged (credited) to other accounts |
|
|
(1,239 |
) |
|
|
1,088 |
|
|
|
(4,819 |
) |
Valuation allowance at end of year |
|
$ |
26,182 |
|
|
$ |
32,318 |
|
|
$ |
118,734 |
|
(1) In 2022, this adjustment relates to a true-up of the investment in partnership deferred tax asset and related valuation allowance which has been updated to remove partnership tax basis that we expect will only reverse upon sale as a capital loss. In 2023, there was an adjustment to the investment in partnership and net operating loss deferred tax assets and related valuation allowance. These adjustments had no net impact to our income tax benefit in either period.
|
| Summary of Unrecognized Tax Benefits |
The following table summarizes the changes in the carrying amount of our unrecognized benefits related to a tax refund in 2024, 2023, and 2022 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
Unrecognized tax benefits at beginning of year |
|
$ |
7,500 |
|
|
$ |
7,500 |
|
|
$ |
— |
|
Tax positions taken in the prior year |
|
|
— |
|
|
|
— |
|
|
|
7,500 |
|
Unrecognized tax benefits at end of year |
|
$ |
7,500 |
|
|
$ |
7,500 |
|
|
$ |
7,500 |
|
|